JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · Issues related to pharmaceutical drugs

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Jan 14, 2026

Lobbying activity 2

Health Issues

Issues related to Domestic manufacturing; Issues related to supply chain resilience

Pharmacy

Issues related to Domestic manufacturing; Issues related to supply chain resilience

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.